To access this element change to forms mode OFF

Grant Award View - GA289031

MEGA-dose aSCORbatE for Sepsis (MEGASCORES): An interdisciplinary...

Contact Details

Department of Health

:
1800020103

:

GA ID:
GA289031
Agency:
Department of Health and Aged Care
Approval Date:
13-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Mar-2028
Value (AUD):
$4,897,652.65 (GST inclusive where applicable)

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
MEGA-dose aSCORbatE for Sepsis (MEGASCORES): An interdisciplinary research program to transform management of sepsis in intensive care units
Purpose:
One in five people die due to sepsis when infection causes organ failure.

Ascorbic acid (vitamin C) may be an effective therapy, but clinical trials to date have failed to show benefit, likely due to inadequate dosing and acidity.

We reported a dramatic reversal of sepsis when mega-doses of the sodium salt of vitamin C is used. Our expert team will conduct a series of studies in animals and then humans to define how sodium ascorbate reverses sepsis and whether this translates to saving lives.

GO ID:
GO Title:
MRFF - 2021 Early to Mid-Career Researchers Grant Opportunity
Internal Reference ID:
2022/MRF2022388
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224

Grant Recipient Location

Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA

Contact Details

Department of Health

:
1800020103

: